Low-molecular weight heparin enoxaparin in the treatment of acute coronary syndromes without ST segment elevation.
Mitrovska S, Jovanova S·Bratislavske lekarske listy
OBJECTIVES: We compared the incidence of adverse cardiac outcomes of enoxaparin vs unfractionated heparin in the management of ACS-NSTE. BACKGROUND: Low-molecular-weight heparins are the potential new standard in the treatment of acute coronary syndromes without ST-segment elevation (ACS-NSTE). The benefit is addresse…